Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Garau

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cost Effectiveness and Resource Allocation : C/E|December 16, 2023
Resource allocation in public sector programmes: does the value of a life differ between governmental departments?Patricia Cubi-Molla, David Mott, Nadine Henderson, et al.
Pharmacoeconomics|May 24, 2011
Using QALYs in cancer: a review of the methodological limitationsMartina Garau, Koonal K Shah, Anne R Mason, et al.
International Journal of Technology Assessment in Health Care|March 14, 2025
Navigating change: a comparative analysis of health technology assessment reforms across agencies - processes, drivers, and interdependenciesGayathri Kumar, Priscila Radu, Patricia Cubi-Molla, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way ForwardRob Baltussen, Kevin Marsh, Praveen Thokala, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cost Effectiveness and Resource Allocation : C/E|December 16, 2023
Resource allocation in public sector programmes: does the value of a life differ between governmental departments?Patricia Cubi-Molla, David Mott, Nadine Henderson, et al.
Pharmacoeconomics|May 24, 2011
Using QALYs in cancer: a review of the methodological limitationsMartina Garau, Koonal K Shah, Anne R Mason, et al.
International Journal of Technology Assessment in Health Care|March 14, 2025
Navigating change: a comparative analysis of health technology assessment reforms across agencies - processes, drivers, and interdependenciesGayathri Kumar, Priscila Radu, Patricia Cubi-Molla, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way ForwardRob Baltussen, Kevin Marsh, Praveen Thokala, et al.
Pageof 2